Viwel Li
FDA investigator
Appears on 1 document from 2025, mostly at sites in China. Most often cites written procedures; deviations (21 CFR 211.100).
- 1
- Documents on file
- 3.0
- Observations per 483
- 2025
- First seen
- 2025
- Most recent
What they cite most
From 3 observations- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
Activity by year
2025: 1
Where
China 1
Often inspects with
Is Viwel Li coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2025-01-06 | 483 Suzhou Suncadia Biopharmaceuticals Co. Ltd.Jan 6, 2025 · Suzhou, China | Suzhou, China | 3 |
About this profile
What does Viwel Li inspect?
Viwel Li appears on 1 document on file covering 1 site, mostly in China.
What do they cite most often?
21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.68.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Viwel Li is dated Jan 6, 2025.